位置:首页 > 蛋白库 > MBEA_ECOLX
MBEA_ECOLX
ID   MBEA_ECOLX              Reviewed;         517 AA.
AC   P13658;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 1.
DT   03-AUG-2022, entry version 66.
DE   RecName: Full=DNA relaxase MbeA;
DE            EC=5.6.2.1;
DE   AltName: Full=DNA nickase;
DE   AltName: Full=Mobilization protein MbeA;
GN   Name=mbeA;
OS   Escherichia coli.
OG   Plasmid ColE1.
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=562;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2671664; DOI=10.1007/bf02464922;
RA   Boyd A.C., Archer J.A.K., Sherratt D.J.;
RT   "Characterization of the ColE1 mobilization region and its protein
RT   products.";
RL   Mol. Gen. Genet. 217:488-498(1989).
RN   [2]
RP   FUNCTION AS A RELAXASE, COFACTOR, DETERMINATION OF THE NIC SITE, AND
RP   MUTAGENESIS OF TYR-19; HIS-97; GLU-104 AND ASN-106.
RX   PubMed=12675806; DOI=10.1046/j.1365-2958.2003.03441.x;
RA   Varsaki A., Lucas M., Afendra A.S., Drainas C., de la Cruz F.;
RT   "Genetic and biochemical characterization of MbeA, the relaxase involved in
RT   plasmid ColE1 conjugative mobilization.";
RL   Mol. Microbiol. 48:481-493(2003).
CC   -!- FUNCTION: Relaxase involved in plasmid ColE1 conjugative mobilization
CC       and is thus essential to promote the specific transfer of the plasmid
CC       during conjugation. First catalyzes the specific cleavage of one of the
CC       DNA strands at oriT, forming a covalent 5'-phosphotyrosine
CC       intermediate. The nic site corresponds to 5'-(1469)CTGG/CTTA(1462)-3'
CC       in the cleaved strand. The cleaved strand is then transferred through
CC       the dedicated type IV secretion apparatus. MbeA remains covalently
CC       linked at the 5' end of the strand, and once in the recipient cell, it
CC       probably catalyzes the rejoining of the two ends of the strand, re-
CC       forming the circular plasmid DNA. Is functional in vitro without a
CC       requirement for the conjugative accessory proteins.
CC       {ECO:0000269|PubMed:12675806}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP-independent breakage of single-stranded DNA, followed by
CC         passage and rejoining.; EC=5.6.2.1;
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:12675806};
CC       Name=Co(2+); Xref=ChEBI:CHEBI:48828;
CC         Evidence={ECO:0000269|PubMed:12675806};
CC       Name=Ni(2+); Xref=ChEBI:CHEBI:49786;
CC         Evidence={ECO:0000269|PubMed:12675806};
CC       Note=Divalent metal cation. Can use Mg(2+), Co(2+) or Ni(2+) with
CC       similar efficiencies, but is not active in the presence of Mn(2+).
CC       {ECO:0000269|PubMed:12675806};
CC   -!- SUBUNIT: Interacts with MbeB and MbeC to form the relaxosome.
CC   -!- INTERACTION:
CC       P13658; P13657: mbeC; NbExp=2; IntAct=EBI-7798346, EBI-7798318;
CC   -!- MISCELLANEOUS: The 100 C-terminal amino acids are dispensable for
CC       activity.
CC   -!- SIMILARITY: To E.coli MbaA and MbkA. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X15873; CAA33883.1; -; Genomic_DNA.
DR   PIR; JQ0390; JQ0390.
DR   AlphaFoldDB; P13658; -.
DR   SMR; P13658; -.
DR   IntAct; P13658; 1.
DR   MINT; P13658; -.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003917; F:DNA topoisomerase type I (single strand cut, ATP-independent) activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   InterPro; IPR005094; Endonuclease_MobA/VirD2.
DR   Pfam; PF03432; Relaxase; 1.
PE   1: Evidence at protein level;
KW   Cobalt; Conjugation; DNA-binding; Isomerase; Magnesium; Metal-binding;
KW   Mobility protein; Nickel; Plasmid; Topoisomerase.
FT   CHAIN           1..517
FT                   /note="DNA relaxase MbeA"
FT                   /id="PRO_0000068400"
FT   REGION          281..310
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          380..405
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          496..517
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        294..310
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        19
FT                   /note="O-(5'-phospho-DNA)-tyrosine intermediate"
FT   BINDING         97
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000305"
FT   BINDING         104
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000305"
FT   BINDING         106
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000305"
FT   MUTAGEN         19
FT                   /note="Y->A: Loss of in vitro DNA-cleavage activity and in
FT                   vivo functionality."
FT                   /evidence="ECO:0000269|PubMed:12675806"
FT   MUTAGEN         97
FT                   /note="H->A: Loss of in vitro DNA-cleavage activity and in
FT                   vivo functionality. No effect on DNA binding around the nic
FT                   site."
FT                   /evidence="ECO:0000269|PubMed:12675806"
FT   MUTAGEN         104
FT                   /note="E->A: Loss of in vitro DNA-cleavage activity and in
FT                   vivo functionality. No effect on DNA binding around the nic
FT                   site."
FT                   /evidence="ECO:0000269|PubMed:12675806"
FT   MUTAGEN         104
FT                   /note="E->H: Loss of the in vitro DNA-cleavage and strand-
FT                   transfer activities but displays 1% of the in vivo wild-
FT                   type activity; when associated with H-106."
FT                   /evidence="ECO:0000269|PubMed:12675806"
FT   MUTAGEN         106
FT                   /note="N->A: 4-fold and 3-fold reduction in the in vitro
FT                   DNA-cleavage and strand-transfer activities, respectively,
FT                   but no reduction in the in vivo functionality."
FT                   /evidence="ECO:0000269|PubMed:12675806"
FT   MUTAGEN         106
FT                   /note="N->H: Loss of the in vitro DNA-cleavage and strand-
FT                   transfer activities but displays 1% of the in vivo wild-
FT                   type activity; when associated with H-104."
FT                   /evidence="ECO:0000269|PubMed:12675806"
SQ   SEQUENCE   517 AA;  57808 MW;  278E41B2D3B2A08A CRC64;
     MIVKFHARGK GGGSGPVDYL LGRERNREGA TVLQGNPEEV RELIDATPFA KKYTSGVLSF
     AEKELPPGGR EKVMASFERV LMPGLEKNQY SILWVEHQDK GRLELNFVIP NMELQTGKRL
     QPYYDRADRP RIDAWQTLVN HHYGLHDPNA PENRRTLTLP DNLPETKQAL AEGVTRGIDA
     LYHAGEIKGR QDVIQALTEA GLEVVRVTRT SISIADPNGG KNIRLKGAFY EQSFADGRGV
     REKAERESRI YRENAEQRVQ EARRICKRGC DIKRDENQRR YSPVHSLDRG IAGKTPGRGE
     RGDDAAQEGR VKAGREYGHD VTGDSLSPVY REWRDALVSW REDTGEPGRN QEAGRDIAET
     EREDMGRGVC AGREQEIPCP SVREISGGDS LSGERVGTSE GVTQSDRAGN TFAERLRAAA
     TGLYAAAERM GERLRGIAED VFAYATGQRD AERAGHAVES AGAALERADR TLEPVIQREL
     EIREERLIQE REHVLSLERE RQPEIQERTL DGPSLGW
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024